# Gene Therapy for X-linked Chronic Granulomatous Disease (CGD) in Children

> **NCT00927134** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Zurich** · enrollment: 2 (actual)

## Conditions studied

- Chronic Granulomatous Disease

## Interventions

- **GENETIC:** retroviral SF71-gp91phox transduced CD34+ cells

## Key facts

- **NCT ID:** NCT00927134
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2010-12
- **Final completion:** 2011-09
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2011-09-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00927134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00927134, "Gene Therapy for X-linked Chronic Granulomatous Disease (CGD) in Children". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00927134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*